This is a randomized prospective single blind trial to evaluate blood glucose control
overnight under closed-loop insulin delivery with MD-Logic Artificial Pancreas (MDLAP) system
in patients with type 1 diabetes, being conducted in: Tel Aviv, Israel, Ljubljana, Slovenia
and Hannover, Germany; In this study,75 eligible patients will be enrolled.Each subject will
participate in four consecutive over nights under closed-loop with MDLAP, and four additional
over nights under regular sensor augmented pump therapy at home with a washout period of 10 ±
3 days between arms.